Thiago Carvalho on Nostr: 'Roche raised hopes this year that it had a future blockbuster drug on its hands ...

'Roche raised hopes this year that it had a future blockbuster drug on its hands after early trial results of the Swiss pharmaceutical group’s new obesity treatments showed rapid weight loss among recipients.
But revelations earlier this week of high rates of vomiting and other side effects among those who took strong doses of the drugs have unsettled investors and highlighted the challenges facing businesses that want to enter the lucrative new market for “GLP-1” drugs.'
https://www.ft.com/content/23f04a92-37da-4d7e-9244-f8262355bbdc